FAQ
The most common reason is infection; more specifically pneumonias. Ventilator-associated pneumonia (VAP) is a matter of concern in many countries, including the United States. Bacterial growth on endotracheal tubes is a key component in the pathogenesis of VAP which afflicts an estimated 250,000 patients each year and is associated with high morbidity (36,000 deaths). VAP extend ICU stays and are thereby very expensive.
The most common reason is infection; more specifically pneumonias. Ventilator-associated pneumonia (VAP) is a matter of concern in many countries, including the United States. Bacterial growth on endotracheal tubes is a key component in the pathogenesis of VAP which afflicts an estimated 250,000 patients each year and is associated with high morbidity (36,000 deaths). VAP extend ICU stays and are thereby very expensive.
